NEWS AND EVENTS

Access Biologicals is pleased to be a hosting partner of the 7th CAR-TCR Summit. Will we see you there? Check out the preliminary agenda: https://car-tcr-summit.com/program/draft-agenda/ Over 1500 of our cell therapy industry and research peers will be gathering in Boston this September to learn and discuss everything from basic discovery to commercialization and how to accelerate safe, effective and commercially viable cell therapies to market.   Stop by and visit us at the CAR-TCR Summit! Find us at booth A7.

Join us at the 2022 AACC Annual Scientific Meeting & Clinical Lab Expo! The Access Biologicals team will join Grifols Bio Supplies in booth 3653 at the McCormick Place Convention Center in Chicago, Illinois. The meeting takes place July 24th through July 28th. The agenda includes plenary sessions, lectures, roundtable sessions and many other educational opportunities to stay current in your field. We hope to meet you there! Register here

Access Biologicals is actively collecting serum and plasma from patients being vaccinated for COVID-19 COVID-19 J&J, Moderna and Pfizer Vaccine Panels Longitudinal Vaccine Panel  (Moderna) 6 samples per subject Following vaccinated donors pre-vaccine to 6 months post vaccination series completed Sample 1: Pre Vaccine Sample 2: Post 1st dose ​Sample 3: Post 2nd dose Sample 4: 1.5 months post 2nd dose Sample 5: 3.5 months post 2nd dose Sample 6: 6.5 months post 2nd dose • Serum only • 15 donors ​​ 14 Subject Panel (J&J) 3 samples per subject Sample 1: 2 weeks prior to their vaccination Sample 2: 2 weeks post their vaccination Sample 3: 2 months post their vaccination • Some subjects with previous COVID infections • Serum only • 1-2 mL samples • Methodology: DiaSorin LIAISON SARS-CoV-2 S1/S2 IgG 15 Subject Panels (Panel J – Moderna) (Panel K – Pfizer) 3 samples per subject Sample 1: ≤ 2 days prior to the first vaccination Sample 2: ≤ 2 days prior to their second vaccination Sample 3: 13-15 days post their second vaccination • Some subjects with previous COVID infections • Serum only • 1mL samples • Methodology: DiaSorin LIAISON SARS-CoV-2 S1/S2 IgG Pre-COVID-19 Panel (Panel E)​​​​​ • 87 members • ​​​​​​1 sample per subject • 2 mL samples • OTC Serum • Collected pre-pandemic era (March 2017 – Nov 2018) • Age, gender, bleed date and blood type provided Contact us about your needs and we can customize a panel for you. Some of our products are now available to purchase online: Shop here

Access Biologicals is exhibiting at the 2022 American Society of Gene & Cell Therapy Annual Meeting in Miami, FL on January 25th through January 28th. “Advanced Therapies Week is the destination for anyone developing, investing or interested in cell and gene therapies and tissue engineered products. Throughout the week, we’ll be hosting a variety of networking events, focused roundtables and content sessions designed to help biotechs advance along their commercialization journey.” Visit us at booth 639 to meet our knowledgeable staff and learn about our cell culture and cell therapy product portfolios. If you’d like to arrange a meeting in advance, please email info@accessbiologicals.com. For more information and to register: 2022 Advanced Therapies Week

Abstract Seroconversion panels are an important tool for investigating antibody responses in acute and chronic phases of disease and development of serological assays for viral diseases including COVID-19. Globally it is anticipated that vaccines against SARS-CoV-2 will facilitate control of the current pandemic. The two COVID-19 seroconversion panels analyzed in this study were obtained from consenting donors with samples collected before vaccination with the mRNA-1273 vaccine (Moderna) and after the first and second doses of the vaccine. Panel samples were tested for antibodies to SARS-CoV-2 (IgG). Individual subjects with a positive response for anti-SARS-CoV2 IgG in their pre-vaccination samples showed a significantly enhanced response to the first vaccination. In older subjects, weaker immunological responses to the first injection were observed, which were overcome by the second injection. All subjects in the study were positive for anti-SARS-CoV-2 IgG after the second dose of vaccine. View full publication here

Did you know Access Biologicals offers panels for assay development, validation and qualification?! For more information about our products, please visit: Panels, ​​​​COVID-19 Panels & Seroconversion Panels ANA (Antinuclear Antibody) Anti-CCP ((cyclic citrullinated peptide) antibodies in the blood)  APLS (antiphospholipid antibody syndrome) Celiac HSV1 & 2 Interference Panel MMRV (measles, mumps, rubella and varicella) SARS-CoV-2 Crossover panel ToRC Vasculitis Vitamin D COVID-19 Panels Normal, Healthy Serum (87 member) pre-pandemic COVID-19 positive single samples available in serum or K2 EDTA COVID-19 Seroconversion Panels HAV Seroconversion Panels Custom panels are available. Contact us about your needs and we can customize a panel for you. Many of our products are now available to purchase online: Shop here